CUSIP: 67552A108
Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
8,096,260
-
Share change
-
+223,227
-
Total reported value
-
$21,256,000
-
Price per share
-
$2.64
-
Number of holders
-
30
-
Value change
-
+$616,236
-
Number of buys
-
10
-
Number of sells
-
7
Quarterly Holders Quick Answers
What is CUSIP 67552A108?
CUSIP 67552A108 identifies OCRX - OCERA THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2016
-
Previous quarter:
Q2 2016
Recent filing periods for CUSIP 67552A108:
Institutional Holders of OCERA THERAPEUTICS INC - COM (OCRX) as of Q3 2016
As of 30 Sep 2016,
OCERA THERAPEUTICS INC - COM (OCRX) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,096,260 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, VHCP Management II, LLC, QVT Financial LP, VHCP Management, LLC, DEERFIELD MANAGEMENT CO, MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, PURA VIDA INVESTMENTS, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.